0,5

3 trials

Sponsors

H. Lundbeck A/S, Instituto de Ciências Farmacêuticas

Conditions

Disturbances of onset and maintenance of sleepSchizophrenia MedDRA version: 8.1 Level: LLT Classification code 10039626 Term: SchizophreniaSchizophrenia MedDRA version: 10.0 Level: LLT Classification code 10039626 Term:

Phase 1

A clinical study to evaluate the safety and blood concentration of Melatonin sublingual in healthy male research participants

Active, not recruitingRBR-8hc3zf

Instituto de Ciências FarmacêuticasDisturbances of onset and maintenance of sleep

Start: 2018-09-10Updated: 2025-10-27

Phase 3

A double-blind, randomised, placebo-controlled, quetiapine-referenced, multicentre study of the long-term bifeprunox efficacy, safety and tolerability in patiens with stable schizophrenia - N/A

Active, not recruitingEUCTR2005-005499-34-GR

H. Lundbeck A/SSchizophrenia MedDRA version: 8.1 Level: LLT Classification code 10039626 Term: Schizophrenia

Start: 2007-03-13Target: 35Updated: 2018-10-22

Unknown Phase

A one-year multinational, multi-centre, randomised, double-blind, parallel-group, fixed-dose, bifeprunox study combining a 12 week placebo-controlled, quetiapine-referenced phase with a 12-month quetiapine-controlled phase in patients with schizophrenia. - N/A

Active, not recruitingEUCTR2007-001097-90-GR

H. Lundbeck A/SSchizophrenia MedDRA version: 10.0 Level: LLT Classification code 10039626 Term:

Start: 2008-09-23Target: 450Updated: 2012-03-19